| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015981545 |
| P356 | DOI | 10.1038/SJ.BJC.6605420 |
| P932 | PMC publication ID | 2788265 |
| P698 | PubMed publication ID | 19904268 |
| P5875 | ResearchGate publication ID | 38080862 |
| P2093 | author name string | T Scholten | |
| V Heinemann | |||
| R Fietkau | |||
| A Hinke | |||
| R Sauer | |||
| C J Bruns | |||
| R Wilkowski | |||
| M Herbst | |||
| S Boeck | |||
| M Flentje | |||
| H G Rau | |||
| H D Boettcher | |||
| S Miethe | |||
| S Ostermaier | |||
| P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
| Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial | Q29547565 | ||
| Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group | Q29619344 | ||
| Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer | Q33326148 | ||
| Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study | Q33349410 | ||
| A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma | Q33376728 | ||
| Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinair | Q33378806 | ||
| Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer. | Q33381360 | ||
| Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. | Q34557866 | ||
| Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer | Q34570210 | ||
| Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group | Q34579882 | ||
| Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. | Q36494203 | ||
| Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer | Q36539266 | ||
| A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer | Q37080999 | ||
| Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. | Q43800126 | ||
| Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of | Q46604466 | ||
| Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial | Q46748088 | ||
| A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer | Q46876249 | ||
| Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer | Q46958960 | ||
| Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer | Q46966648 | ||
| Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. | Q48464441 | ||
| Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies | Q57758319 | ||
| Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy | Q80407725 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| fluorouracil | Q238512 | ||
| cisplatin | Q412415 | ||
| chemotherapy | Q974135 | ||
| P304 | page(s) | 1853-1859 | |
| P577 | publication date | 2009-11-10 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre ra | |
| P478 | volume | 101 |
| Q37030917 | ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer |
| Q36424167 | Adenosquamous carcinoma of the uncinate process of the pancreas with synchronous gastrointestinal stromal tumor of the stomach: Case report and review of the literature |
| Q52647259 | Chemotherapy and radiotherapy for advanced pancreatic cancer. |
| Q36985745 | Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer |
| Q37097517 | Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study |
| Q36235666 | Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer |
| Q90194029 | Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions |
| Q35934322 | Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. |
| Q38096479 | Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer |
| Q34568226 | Feasibility of automated pancreas segmentation based on dynamic MRI. |
| Q36751555 | Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. |
| Q39279983 | Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients |
| Q39938179 | Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma |
| Q64092030 | Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis |
| Q42374126 | Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients. |
| Q37947452 | Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies |
| Q33402401 | Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer |
| Q84965491 | Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial |
| Q49169537 | Reply to: The definition of locally advanced pancreatic cancer |
| Q36416279 | Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011. |
| Q33755147 | Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191 |
| Q37993393 | Targeting the vasculature of visceral tumors: novel insights and treatment perspectives |
| Q35653846 | The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer |
| Q42752767 | The definition of locally advanced pancreatic cancer |
| Q36552512 | The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer |
Search more.